PubRank

W Fierz

Author PubWeight™ 39.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 1984 3.71
2 Astrocytes as antigen-presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. J Immunol 1985 1.88
3 Assessment of an Interferon-gamma release assay for the diagnosis of latent tuberculosis infection in haemodialysis patient. Swiss Med Wkly 2010 1.50
4 Cerebrospinal fluid immunoglobulins and multiple sclerosis. Correspondence with magnetic resonance imaging and visually evoked potential changes. Arch Neurol 1989 1.44
5 Atypical, cytoplasmic and perinuclear anti-neutrophil cytoplasmic antibodies in patients with inflammatory bowel disease. J Gastroenterol Hepatol 1998 1.41
6 High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. J Acquir Immune Defic Syndr 1999 1.17
7 Serological evidence of human granulocytic ehrlichiosis in Switzerland. Eur J Clin Microbiol Infect Dis 1998 1.11
8 Infrequent detection of lipoarabinomannan antibodies in human immunodeficiency virus-associated mycobacterial disease. Swiss HIV Cohort Study. J Clin Microbiol 1996 1.09
9 Supposed lamarckian inheritance of immunological tolerance. Nature 1981 1.05
10 Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients. Clin Exp Immunol 1991 1.04
11 Astrocytes as antigen-presenting cells. Part II: Unlike H-2K-dependent cytotoxic T cells, H-2Ia-restricted T cells are only stimulated in the presence of interferon-gamma. J Neuroimmunol 1986 0.97
12 Non-H-2 and H-2-linked immune response genes control the cytotoxic T-cell response to H-Y. Immunogenetics 1982 0.95
13 T cell clones with normal or defective O-galactosylation from a patient with permanent mixed-field polyagglutinability. Eur J Immunol 1992 0.92
14 The endothelium--astrocyte immune control system of the brain. Springer Semin Immunopathol 1985 0.92
15 Genetic analysis of the non-H-2-linked Ir genes controlling the cytotoxic T-cell response to H-Y in H-2d mice. Immunogenetics 1982 0.89
16 Pregnancy, immunosuppression and reactivation of latent toxoplasmosis. J Perinat Med 1995 0.89
17 Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study. Ann Neurol 1988 0.88
18 Immune reactivity of progeny of tetraparental male mice. Nature 1981 0.88
19 Electrophysiological investigations in adoptively transferred experimental autoimmune encephalomyelitis in the Lewis rat. Brain 1989 0.88
20 Expert opinion: guidelines for the use of natalizumab in multiple sclerosis patients previously treated with immunomodulating therapies. J Neuroimmunol 2007 0.87
21 T cell approach to demyelinating diseases. Springer Semin Immunopathol 1985 0.85
22 Immune mechanisms in inflammatory polyneuropathy. Ann N Y Acad Sci 1988 0.84
23 Clinical outcome and immunology of postoperative arginine, omega-3 fatty acids, and nucleotide-enriched enteral feeding: a randomized prospective comparison with standard enteral and low calorie/low fat i.v. solutions. Nutrition 1996 0.84
24 The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system. Ann Neurol 1990 0.84
25 The role of macrophages in experimental autoimmune neuritis induced by a P2-specific T-cell line. Ann Neurol 1988 0.83
26 Clinical and immune modulatory effects of alternative weekly interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinoma and melanoma. Br J Cancer 1991 0.82
27 Immunization-induced decrease of the CD4+:CD8+ ratio in cats experimentally infected with feline immunodeficiency virus. Vet Immunol Immunopathol 1992 0.82
28 Specific haplotype preference in congenic F1 hybrid mice in the cytotoxic T cell response to the male specific antigen H-Y. J Immunol 1981 0.82
29 High proportion of gamma-delta T cell receptor positive T cells in bronchoalveolar lavage and peripheral blood of HIV-infected patients with Pneumocystis carinii pneumonias. Respiration 1993 0.80
30 Further studies on supposed lamarckian inheritance of immunological tolerance. Nature 1982 0.80
31 Using a neural network to identify potential HLA-DR1 binding sites within proteins. J Mol Recognit 1993 0.79
32 On the role of astrocytes in polyclonal T cell activation. J Neuroimmunol 1986 0.78
33 Suppression of P2-T cell line-mediated experimental autoimmune neuritis by interleukin-2 receptor targeted monoclonal antibody ART 18. Brain Res 1989 0.78
34 Immunodeficiency after major trauma and selective surgery. Pediatr Infect Dis J 1988 0.78
35 [The prognostic value of different patterns of change in the CD4 lymphocyte counts in 420 symptom-free HIV-1-infected persons]. Dtsch Med Wochenschr 1993 0.77
36 Heterogeneous binding and killing behaviour of human gamma/delta-TCR+ lymphokine-activated killer cells against K562 and Daudi cells. Cancer Immunol Immunother 1993 0.76
37 Chronic relapsing experimental allergic neuritis induced by repeated transfer of P2-protein reactive T cell lines. Brain 1991 0.76
38 Areas of sequence homology between several staphylococcal exotoxin "superantigens" and the HIV-1 pol protein. AIDS Res Hum Retroviruses 1992 0.75
39 Sensitization to human immunodeficiency virus in seronegative exposed partners. J Infect Dis 2000 0.75
40 [The natural history and laboratory parameters of HIV infection]. Dtsch Med Wochenschr 1989 0.75
41 T lymphocyte lines in the study of autoimmune disease. Blut 1984 0.75
42 Graduation of immunosuppression after surgery or severe trauma. Prog Clin Biol Res 1989 0.75
43 [Immunologic changes and infection in severely injured patients]. Schweiz Med Wochenschr 1989 0.75
44 The Sézary syndrome. Dermatologica 1979 0.75
45 [The effect of rejection crises and immunosuppressive therapy on the lymphocyte subpopulations of patients after kidney transplantation]. Klin Wochenschr 1990 0.75
46 [The Sézary syndrome]. Schweiz Med Wochenschr 1976 0.75
47 [Loss of 2 kidney grafts due to recurrence of type II membrano-proliferative glomerulonephritis]. Schweiz Med Wochenschr 1980 0.75
48 Suppression of P2-T-cell line mediated experimental autoimmune neuritis by interleukin-2 receptor blockade. Ann N Y Acad Sci 1988 0.75
49 Adoptive transfer experimental autoimmune encephalomyelitis. Evidence for central nerve and spinal root dysfunction. Ann N Y Acad Sci 1988 0.75
50 [Immunosuppression caused by surgery and severe trauma]. Helv Chir Acta 1989 0.75
51 Identification of Borrelia afzelii in a juxta-articular fibroid nodule from a human immunodeficiency virus-positive patient with acrodermatitis chronica atrophicans. Arch Dermatol 1995 0.75
52 T lymphocyte autoimmunity in experimental autoimmune encephalomyelitis. Concepts Immunopathol 1985 0.75
53 Ciclosporin A prevents P2 T cell line-mediated experimental autoimmune neuritis (AT-EAN) in rat. Neurosci Lett 1987 0.75
54 T cell response to staphylococcal superantigens by asymptomatic HIV-infected individuals exhibits selective changes in T cell receptor V beta-chain usage. AIDS Res Hum Retroviruses 1993 0.75
55 An electronic study form to support collaborating agents in the management of clinical knowledge. Methods Inf Med 1999 0.75
56 Conception of an XML-based ontology for a Web-based medical information service. Stud Health Technol Inform 2000 0.75
57 Immune mechanisms in acute and chronic inflammatory polyneuropathies. J Neuroimmunol 1988 0.75
58 [The role of T-lymphocytes in organ-specific autoimmune diseases]. Schweiz Med Wochenschr 1987 0.75
59 [HIV serological parameters in the prognosis and follow-up assessment of an HIV infection]. Schweiz Med Wochenschr 1988 0.75
60 [Disseminated mycobacteriosis with M. kansasii in a case of AIDS without HIV infection]. Schweiz Med Wochenschr 1997 0.75